FDA — authorised 9 December 2010
- Application: BLA020772
- Marketing authorisation holder: QOL MEDCL
- Indication: REMS
- Status: approved
🇺🇸 Sucraid in United States
FDA authorised Sucraid on 9 December 2010
Marketing authorisation
Sucraid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Sucraid approved in United States?
Yes. FDA authorised it on 9 December 2010.
Who is the marketing authorisation holder for Sucraid in United States?
QOL MEDCL holds the US marketing authorisation.